Drug
Padsevonil
Padsevonil: highest development phase Phase 1, developed by UCB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- UCB
Trials
| Drug | Phase | Indication |
|---|---|---|
| Padsevonil NCT04136444 | Phase 1 | Healthy Study Participants |
Latest
No recent events.
Follow Padsevonil on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.